Finding a unifying SLE expression signature in a sea of heterogeneity

Nature Reviews Rheumatology, Published online: 05 May 2020; doi:10.1038/s41584-020-0422-4The heterogeneity of systemic lupus erythematosus (SLE) confounds the diagnosis and treatment of this disease, and attempts at disease stratification are nascent. Researchers have identified a common set of biomarkers in patients with SLE that could identify new therapeutic targets and lead to new clinical assays to help address this issue.

Source: Nature Reviews Rheumatology - May 4, 2020 Category: Rheumatology Authors: Edward Wakeland Prithvi Raj Source Type: research